Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Head and Neck Neoplasms 1

Interventions

Immunohistochemistry 5Polymerase Chain Reaction 3Gene Expression Profiling 3Biopsy 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2Observation 2Mass Spectrometry 2Immunoenzyme Techniques 2Chemotherapy, Adjuvant 2trastuzumab deruxtecan 1pyrotinib 1bicalutamide 1X-Ray Therapy 1Tissue Array Analysis 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Quality of Life 1Psychiatric Rehabilitation 1Physical Therapy Modalities 1Phlebotomy 1Patient Reported Outcome Measures 1Paclitaxel 1Oligonucleotide Array Sequence Analysis 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Salivary Gland Neoplasms × Tissue Array Analysis × Clear all
NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡